{"name":"Stemgen","slug":"stemgen","ticker":"","exchange":"","domain":"","description":"Ancestim is a recombinant methionyl human stem cell factor, branded by Amgen as StemGen. It was developed by Amgen and sold to Biovitrium, now Swedish Orphan Biovitrum, in December, 2008.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":-491999,"cash":80,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2013"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"date":"2022-08-04","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: FORM 10-Q QUARTERLY REPORT FOR 03-31-2022","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2022-02-23","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: FORM 10-Q QUARTERLY REPORT FOR 12-31-2021","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2022-02-07","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: FORM 10-Q QUARTERLY REPORT FOR 09-30-2021","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2021-10-15","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: FORM 10-K ANNUAL REPORT FOR 06-30-2021","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2021-05-24","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: FORM 10-Q QUARTERLY REPORT FOR 03-31-2021","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2021-02-22","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: FORM 10-Q QUARTERLY REPORT FOR 12-31-2020","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2021-02-08","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K CURRENT REPORT FOR 01-01-2021","headline":"SEC 8-K: FORM 8-K CURRENT REPORT FOR 01-01-2021","sentiment":"neutral"},{"date":"2020-11-16","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: FORM 10-Q QUARTERLY REPORT FOR 09-30-2020","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2020-10-09","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: FORM 10-K ANNUAL REPORT FOR 06-30-2020","headline":"Annual Report (10-K) Filed","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar","revenue":0,"revenuePeriod":"2013-06-30","revenueHistory":[{"value":0,"period":"2013-06-30"},{"value":0,"period":"2012-06-30"},{"value":0,"period":"2011-06-30"}],"grossProfit":0,"grossProfitHistory":[],"rdSpend":null,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-491999,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":80,"cashHistory":[],"totalAssets":80,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":null}